Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Lakehead University

$25,000.00

Synthetic NOD-like receptor ligands for modulating immune responses

EF 2014-15

Résumé
The rise of bacterial resistance to antibiotics has become a worldwide problem. In many developed countries, it is estimated that livestock consume 50-80% of antibiotics which are used not only to treat active infections but also prophylactically to prevent infections. In order to reduce the use of antibiotics in farm animals, we need to improve the efficacy of currently existing methods to control infections in farm animals. Boosting the immune system of livestock will allow these animals to better fight against various infections. Alberta Research Chemicals Inc. (ARCI) is currently developing novel immunostimulatory nanoparticle-based drug delivery systems that will be used to deliver veterinary health products to herd animals. To address ARCI's need for new immunostimulatory agents, we plan to synthesize a few muramyl dipeptide mimics that potentially target the NOD-like receptor and activate the immune system. Following the completion of their synthesis, these compounds will be tested for their immunostimulatory activity and incorporated in nanoparticle-based formulations for further biological studies. The proposed research will facilitate the establishment of research collaboration between the applicant and ARCI, and generate new intellectual properties in the development of veterinary health products. The research outcome may eventually translateinto significant economic and social benefits to Canada.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
469917-2014
Name nom
Jiang, ZiHua
Department département
Chemistry
Organization id
25
Institution établissement
Lakehead University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Synthetic NOD-like receptor ligands for modulating immune responses
Keyword
NSERC
Application summary
The rise of bacterial resistance to antibiotics has become a worldwide problem. In many developed countries, it is estimated that livestock consume 50-80% of antibiotics which are used not only to treat active infections but also prophylactically to prevent infections. In order to reduce the use of antibiotics in farm animals, we need to improve the efficacy of currently existing methods to control infections in farm animals. Boosting the immune system of livestock will allow these animals to better fight against various infections. Alberta Research Chemicals Inc. (ARCI) is currently developing novel immunostimulatory nanoparticle-based drug delivery systems that will be used to deliver veterinary health products to herd animals. To address ARCI's need for new immunostimulatory agents, we plan to synthesize a few muramyl dipeptide mimics that potentially target the NOD-like receptor and activate the immune system. Following the completion of their synthesis, these compounds will be tested for their immunostimulatory activity and incorporated in nanoparticle-based formulations for further biological studies. The proposed research will facilitate the establishment of research collaboration between the applicant and ARCI, and generate new intellectual properties in the development of veterinary health products. The research outcome may eventually translateinto significant economic and social benefits to Canada.